Genentech Inc Provisional
FDA Flags (2)
Class II RecallJun 2024
Genentech, Inc.
Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64
Classification: Class II
Class III RecallNov 2022
Genentech Inc
Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One Su
Classification: Class III